These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
113 related articles for article (PubMed ID: 5691579)
1. Alternate-day steroid regimen in the treatment of ocular disease. Schutz S; Newhouse R; Russo JD Br J Ophthalmol; 1968 Jun; 52(6):461-3. PubMed ID: 5691579 [No Abstract] [Full Text] [Related]
2. [The clinical use of rifampicin with special reference to tuberculous uveitis. (Preliminary results)]. Esente I; Capaccini A Ann Ottalmol Clin Ocul; 1969 Jan; 95(1):78-90. PubMed ID: 5407982 [No Abstract] [Full Text] [Related]
3. Experience of the use of indomethacin in inflammatory eye diseases. Tuovinen E; Esilä R; Liesmaa M Acta Ophthalmol (Copenh); 1966; 44(4):585-9. PubMed ID: 6013044 [No Abstract] [Full Text] [Related]
4. [Apropos of the clinical use of the long-acting betamethasone preparation (celestone chronodose) in ophtalmology]. Faggioni R Schweiz Med Wochenschr; 1968 Jun; 98(26):976-9. PubMed ID: 5304126 [No Abstract] [Full Text] [Related]
5. Peripheral retinitis and chronic cyclitis in children. Hogan MJ; Kimura SJ; O'Connor GR Trans Ophthalmol Soc U K (1962); 1965; 85():39-52. PubMed ID: 5227196 [No Abstract] [Full Text] [Related]
7. [Drug treatment of inflammatory and infectious endogenous inflammations of the eye]. Witmer R Klin Monbl Augenheilkd; 1985 Jun; 186(6):424-7. PubMed ID: 3876473 [TBL] [Abstract][Full Text] [Related]
8. [Treatment of ocular inflammatory disease with glucocorticoids and cyclophosphamide pulses]. Cuchacovich M; Verdaguer JI; Gatica H; López JM; Verdaguer J Rev Med Chil; 1995 Jul; 123(7):865-73. PubMed ID: 8560118 [TBL] [Abstract][Full Text] [Related]
9. Intra-ocular medication with special reference to depomedrone. Phillpotts JS Trans Ophthalmol Soc U K (1962); 1969; 88():729-35. PubMed ID: 5272289 [No Abstract] [Full Text] [Related]
10. [Prescription of corticotherapy on alternate days for long periods]. Akoun G; Vachon J; Muon N; Brocard H Sem Hop; 1968 Dec; 44(51):3141-9. PubMed ID: 4308277 [No Abstract] [Full Text] [Related]
11. [Use of rifampicin in ophthalmology]. Musini A; Cattani F; Bonora F Arch Ophtalmol Rev Gen Ophtalmol; 1970 Nov; 30(11):809-16. PubMed ID: 4250391 [No Abstract] [Full Text] [Related]
12. The influence of Graves' orbitopathy treatment with intravenous glucocorticoids on adrenal function. Ambroziak U; Bluszcz G; Bednarczuk T; Miśkiewicz P Endokrynol Pol; 2017; 68(4):430-433. PubMed ID: 28604944 [TBL] [Abstract][Full Text] [Related]
13. [Indications and contraindications for the use of corticosteroids in ophthalmology]. Henkes HE Ned Tijdschr Geneeskd; 1977 Oct; 121(41):1605-7. PubMed ID: 561899 [No Abstract] [Full Text] [Related]
15. Clinical investigations on the effect of glucocorticoids on intraocular tension. Prus-Sawicka K Pol Med J; 1969; 8(6):1450-5. PubMed ID: 5392605 [No Abstract] [Full Text] [Related]
16. [Adrenocortical insufficiency due to therapy with corticosteroids]. Baumann K; Müller J Ther Umsch; 1972 Sep; 29(9):535-9. PubMed ID: 4343770 [No Abstract] [Full Text] [Related]
17. [11-beta-hydroxy-6-alpha-methyl-progesterone (a new synthetic corticosteroid with an anti-inflammatory effect and no ocular hypertensive action)]. Palmieri L; Mazzilli G Ann Ottalmol Clin Ocul; 1968 Oct; 94(10):1295-304. PubMed ID: 5733457 [No Abstract] [Full Text] [Related]
18. [Case of serious complications caused by steroids used in the therapy of sclera-uveitis]. Fukuda T; Nishimura H Ganka; 1966 Nov; 8(11):933-9. PubMed ID: 6009787 [No Abstract] [Full Text] [Related]
19. Ophthalmic use of glucocorticoids. Brightman AH Vet Clin North Am Small Anim Pract; 1982 Feb; 12(1):33-9. PubMed ID: 7048713 [No Abstract] [Full Text] [Related]
20. [Aspects of treatment with immunosuppressive agents in ophthalmology]. Micşa MV; Weinberg J; Ciocan I; Zapolschi D; Popovici S Rev Chir Oncol Radiol O R L Oftalmol Stomatol Ser Oftalmol; 1981; 25(3):233-5. PubMed ID: 6460300 [No Abstract] [Full Text] [Related] [Next] [New Search]